IDEAYA Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update
Provided By PR Newswire
Last update: Nov 4, 2025
SOUTH SAN FRANCISCO, Calif., Nov. 4, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, provided a business update and announced financial results for the third quarter ended September 30, 2025.
Read more at prnewswire.com
